Langballe, Ellen Melbye http://orcid.org/0000-0002-8536-510X
Skirbekk, Vegard http://orcid.org/0000-0002-1647-3246
Strand, Bjørn Heine http://orcid.org/0000-0003-4385-8886
Funding for this research was provided by:
University of Oslo
Article History
Accepted: 8 February 2023
First Online: 28 February 2023
Change Date: 21 April 2023
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s10433-023-00757-y
Declarations
:
: The authors declare no competing interests.
: The authors do not have any conflict of interest or declarations of funding.
: NORSE was assessed by the Norwegian Regional Ethics Committee for medical research (REC), which in a decision of 25.06.2015 (2015/970/REK south-east) concluded that the treatment involves the establishment of a health register and that the project therefore falls outside the scope of the Health Research Act. An application was therefore made for a license pursuant to section 7 of the Health Register Act, cf. Section 33 of the Personal Data Act. This license was granted 18.10.2016, and NORSE was then officially defined as a health registry, and the study, including all experimental protocols, was approved by the Norwegian data inspectorate (Reference number 16/00929–2/GRA). All methods were carried out in accordance with relevant guidelines and regulations. Written informed consent was obtained from all NORSE participants at inclusion but not for this specific study. This study is assessed and approved by The Norwegian Centre for Research Data (reference number 501185).